Literature DB >> 18841306

Anti-inflammatory activity of Crinum asiaticum Linne var. japonicum extract and its application as a cosmeceutical ingredient.

Young Heui Kim1, Ki Ho Kim, Chang Sung Han, Sun Hee Park, Hong Chul Yang, Bang Yong Lee, Sang-Yong Eom, Young-Sil Kim, Jong-Heon Kim, Nam Ho Lee.   

Abstract

Crinum asiaticum Linne var. japonicum has long been used as a rheumatic remedy, as an anti-pyretic and as an anti-ulcer treatment, and for the alleviation of local pain and fever in Korea and Malaysia. In order to investigate the possibility of Crinum asiaticum Linne var. japonicum extract as a cosmetic ingredient, we measured its anti-inflammatory effect by its inhibition of iNOS (inducible nitric oxide synthase) and the release of PGE2, IL-6, and IL-8. We also measured its anti-allergic effect by its inhibition of beta-hexosamidase release. An HPLC experiment after extraction with 95% EtOH at pH 3.5 showed that Crinum asiaticum Linne var. japonicum was mainly composed of lycorine (up to 1%), a well-known immunosuppressor. The content of lycorine varied, depending on the type of plant tissue analyzed and the extraction method. In an anti-inflammatory assay for inhibition of nitric oxide formation on lipopolysaccharide (LPS)-activated mouse macrophage RAW 264.7 cells, the ethanol extract of Crinum asiaticum showed an inhibitory activity of NO production in a dose-dependent manner (IC50 = 58.5 microg/ml). Additional study by RT-PCR demonstrated that the extract of Crinum asiaticum significantly suppressed the expression of the iNOS gene. Moreover, the extract of Crinum asiaticum did not show any cytotoxicity, but did show a cell proliferation effect against LPS (a 10 approximately 60% increase in cell viability). In an assay to determine inhibition of the H2O2-activated release of PGE2, IL-6, and IL-8 in human normal fibroblast cell lines, the release of PGE2 and IL-6 was almost completely inhibited above concentrations of 0.05% and 1%, respectively. Moreover, the release of IL-8 was completely inhibited over the entire range of concentration (>0.0025%). In order to investigate the skin-sensitizing potentials of the extract of Crinum asiaticum, a human clinical test was performed after repeated epicutaneous 48-h applications under an occlusive patch (RIPT). The repeated and single cutaneous applications of Crinum asiaticum Linne var. japonicum extract under the occlusive patch did not provoke any cumulative irritation and sensitization reactions. The result showed that the extract of Crinum asiaticum Linne var. japonicum has a sufficient anti-inflammatory effect. Therefore, Crinum asiaticum Linne var. japonicum extract may be useful for development as an ingredient in cosmetic products.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841306

Source DB:  PubMed          Journal:  J Cosmet Sci        ISSN: 1525-7886            Impact factor:   0.948


  4 in total

1.  Evaluation of the anti-inflammatory effect of an anti-platelet agent crinumin on carrageenan-induced paw oedema and granuloma tissue formation in rats.

Authors:  Uddipak Rai; Amrita Rawal; Sanjay Singh
Journal:  Inflammopharmacology       Date:  2017-12-02       Impact factor: 4.473

Review 2.  A Review of Malaysian Medicinal Plants with Potential Anti-Inflammatory Activity.

Authors:  Fazleen Izzany Abu Bakar; Mohd Fadzelly Abu Bakar; Norazlin Abdullah; Susi Endrini; Asmah Rahmat
Journal:  Adv Pharmacol Sci       Date:  2018-07-09

3.  Tandem mass tag-based quantitative proteomic analysis of lycorine treatment in highly pathogenic avian influenza H5N1 virus infection.

Authors:  Li Yang; Jia Hao Zhang; Xiao Li Zhang; Guang Jie Lao; Guan Ming Su; Lei Wang; Yao Lan Li; Wen Cai Ye; Jun He
Journal:  PeerJ       Date:  2019-10-02       Impact factor: 2.984

Review 4.  The Phytochemistry and Pharmacology of Tulbaghia, Allium, Crinum and Cyrtanthus: 'Talented' Taxa from the Amaryllidaceae.

Authors:  Cynthia Amaning Danquah; Prince Amankwah Baffour Minkah; Theresa A Agana; Phanankosi Moyo; Michael Ofori; Peace Doe; Sibusiso Rali; Isaiah Osei Duah Junior; Kofi Bonsu Amankwah; Samuel Owusu Somuah; Isaac Newton Nugbemado; Vinesh J Maharaj; Sanjib Bhakta; Simon Gibbons
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.